Healthpeak Properties
DOC Β· Health Care REITs
$19.25
0.5%Healthcare Realty Trust
HR Β· Health Care REITs
$17.95
0.1%The short version
- Healthpeak Properties is the larger business, with $2.8B of revenue in fiscal 2025 against $1.2B for Healthcare Realty Trust, about 2.4 times as much.
- Healthpeak Properties grew revenue faster (4.5%, against β6.9%).
- Healthpeak Properties turned more of its sales into free cash flow (12.7% FCF margin, against 10.8% FCF margin).
| Latest fiscal year | DOC Β· FY25 | HR Β· FY25 |
|---|---|---|
| Size | ||
| Market cap | $13.3B | $6.1B |
| Revenue | $2.8B | $1.2B |
| Free cash flow | $357M | $127M |
| Net income | $71.3M | β$246M |
| Growth | ||
| Revenue growth | 4.5% | β6.9% |
| 5-year growth | 11.4% | 18.8% |
| Share count change | 2.9% | β4.3% |
| Profitability | ||
| Gross margin | 60.0% | β |
| Operating margin | β | β |
| Net margin | 2.5% | β20.8% |
| FCF margin | 12.7% | 10.8% |
| Return on capital | 3.2% | β |
| Return on equity | 0.9% | β5.0% |
| Balance sheet | ||
| Net debt | $9.4B | $4.0B |
| Net debt / EBITDA | 5.7x | β |
| Dividends and buybacks | $946M | $391M |
| Valuation & quality | ||
| P/E | 55.0x | β |
| Piotroski F-score | β | β |
FY16
DOC $2.1B
HR $461M
FY17
DOC $1.8B
HR $614M
FY18
DOC $1.2B
HR $696M
FY19
DOC $1.2B
HR $692M
FY20
DOC $1.6B
HR $500M
FY21
DOC $1.9B
HR $535M
FY22
DOC $2.1B
HR $933M
FY23
DOC $2.2B
HR $1.3B
FY24
DOC $2.7B
HR $1.3B
FY25
DOC $2.8B
HR $1.2B
DOC
HR
FY16
DOC β
HR 22.1%
FY17
DOC β
HR 20.1%
FY18
DOC β
HR β
FY19
DOC β
HR β
FY20
DOC β
HR β
FY21
DOC β
HR β
FY22
DOC β
HR β
FY23
DOC β
HR β
FY24
DOC β
HR β
FY25
DOC β
HR β
DOC
HR
FY16
DOC $755M
HR $161M
FY17
DOC $375M
HR $243M
FY18
DOC $288M
HR $260M
FY19
DOC $169M
HR $249M
FY20
DOC β$30.5M
HR $395M
FY21
DOC $35.5M
HR $135M
FY22
DOC β$61.7M
HR $109M
FY23
DOC $182M
HR $269M
FY24
DOC $334M
HR $253M
FY25
DOC $357M
HR $127M
DOC
HR
FY16
DOC 1.6%
HR 2.5%
FY17
DOC 2.3%
HR 2.0%
FY18
DOC 1.6%
HR β
FY19
DOC 1.3%
HR β
FY20
DOC 3.3%
HR β
FY21
DOC 2.1%
HR β
FY22
DOC 5.1%
HR β
FY23
DOC 3.8%
HR β
FY24
DOC 3.5%
HR β
FY25
DOC 3.2%
HR β
DOC
HR
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.